Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Neural Transmission Année : 2023

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease

Résumé

Dopaminergic therapies dominate the treatment of the motor and non-motor symptoms of Parkinson’s disease (PD) but there have been no major advances in therapy in many decades. Two of the oldest drugs used appear more effective than others-levodopa and apomorphine-but the reasons for this are seldom discussed and this may be one cause for a lack of progress. This short review questions current thinking on drug action and looks at whether adopting the philosophy of ex-US Secretary of State Donald Rumsfeld reveals ’unknown’ aspects of the actions of levodopa and apomorphine that provide clues for a way forward. It appears that both levodopa and apomorphine have a more complex pharmacology than classical views would suggest. In addition, there are unexpected facets to the mechanisms through which levodopa acts that are either forgotten as ’known unknowns’ or ignored as ’unknown unknowns’. The conclusion reached is that we may not know as much as we think about drug action in PD and there is a case for looking beyond the obvious.
Fichier principal
Vignette du fichier
s00702-023-02655-0.pdf (672.27 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04120383 , version 1 (07-06-2023)

Licence

Paternité

Identifiants

Citer

P Jenner, C Falup-Pecurariu, V Leta, M Vérin, M Auffret, et al.. Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease. Journal of Neural Transmission, 2023, 130 (11), pp.1337-1347. ⟨10.1007/s00702-023-02655-0⟩. ⟨hal-04120383⟩
18 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More